32 studies found for:
"hemochromatosis"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
|
||||
| 2 | Recruiting |
Treatment of Hemochromatosis
|
||||
| 3 | Active, not recruiting |
Cardiac Function in Patients With Hereditary Hemochromatosis
|
||||
| 4 |
Completed
Has Results |
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
|
||||
| 5 | Recruiting |
Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
|
||||
| 6 | Recruiting |
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
|
||||
| 7 | Recruiting |
Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
|
||||
| 8 | Recruiting |
HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
|
||||
| 9 | Completed |
Deferoxamine for the Treatment of Hemochromatosis
|
||||
| 10 | Not yet recruiting |
Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis
|
||||
| 11 | Completed |
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
|
||||
| 12 | Completed |
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
|
||||
| 13 | Completed |
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
|
||||
| 14 | Completed |
Hemochromatosis--Genetic Prevalence and Penetrance
|
||||
| 15 | Completed |
Hemochromatosis and Iron Overload Screening Study (HEIRS)
|
||||
| 16 | Completed |
Statistical Basis for Hemochromatosis Screening
|
||||
| 17 | Completed |
Iron Overload in African Americans
|
||||
| 18 | Completed |
Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration
|
||||
| 19 | Completed |
Oral Nifedipine to Treat Iron Overload
|
||||
| 20 | Completed |
Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
|
† Indicates status has not been verified in more than two years
